Login / Signup

Photovoltaic implant simulator reveals resolution limits in subretinal prosthesis.

Zhijie Charles ChenBing-Yi WangAnna Kochnev GoldsteinEmma ButtKeith MathiesonDaniel Palanker
Published in: Journal of neural engineering (2022)
Objective. PRIMA, the photovoltaic subretinal prosthesis, restores central vision in patients blinded by atrophic age-related macular degeneration (AMD), with a resolution closely matching the 100 µ m pixel size of the implant. Improvement in resolution requires smaller pixels, but the resultant electric field may not provide sufficient stimulation strength in the inner nuclear layer (INL) or may lead to excessive crosstalk between neighboring electrodes, resulting in low contrast stimulation patterns. We study the approaches to electric field shaping in the retina for prosthetic vision with higher resolution and improved contrast. Approach. We present a new computational framework, Retinal Prosthesis Simulator (RPSim), that efficiently computes the electric field in the retina generated by a photovoltaic implant with thousands of electrodes. Leveraging the PRIMA clinical results as a benchmark, we use RPSim to predict the stimulus strength and contrast of the electric field in the retina with various pixel designs and stimulation patterns. Main results. We demonstrate that by utilizing monopolar pixels as both anodes and cathodes to suppress crosstalk, most patients may achieve resolution no worse than 48 µ m. Closer proximity between the electrodes and the INL, achieved with pillar electrodes, enhances the stimulus strength and contrast and may enable 24 µ m resolution with 20 µ m pixels, at least in some patients. Significance. A resolution of 24 µ m on the retina corresponds to a visual acuity of 20/100, which is over 4 times higher than the current best prosthetic acuity of 20/438, promising a significant improvement of central vision for many AMD patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • magnetic resonance
  • peritoneal dialysis
  • single molecule
  • clinical trial
  • perovskite solar cells